1. Home
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Europe Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

Europe Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

  • November 2022
  • 191 pages
  • ID: 6368893
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The embolotherapy market in Europe is expected to grow from US$ 1,050.81 million in 2022 to US$ 1,638.92 million by 2028. It is estimated to grow at a CAGR of 7.7% from 2022 to 2028.

Rising Prevalence of Cancer Drives Growth of Embolotherapy Market in Europe

The five most common types of cancer are breast cancer, prostate cancer, cervical cancer, lung cancer, and colorectal cancer.Among these five cancer types, the leading cause of cancer-related death is lung cancer.

Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. In Denmark, the highest cancer rate for men and women combined was 334.9 people per 100,000. The age-standardized rate was at least 300 per 100,000 for ten countries—Denmark, Hungary, Ireland, Belgium, France, Australia, the Netherlands, Norway, France (New Caledonia), and Slovenia. In 2018, an estimated 233,000 women and 265,000 men in Germany were newly diagnosed with cancer. The total number of new cases per year has stagnated at around 500,000 for about ten years. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal tissue area. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing agents, including embolic microspheres (beads), are used to restrict the vascular supply of tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain tumor types, and arteriovenous malformations. The pipeline embolization device is used for the treatment of large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Market Overview

The embolotherapy market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the rest of Europe.The market growth in the region is attributed to the increasing prevalence of cancers and brain aneurysms; rising preference for minimally invasive procedures; and surging investments, funds, and grants by public–private organizations for research.

However, a dearth of skilled surgeons restrains the market growth.Germany is one of the significantly developed economies in Europe.

Healthcare expenditure is increasing in Germany. Germany’s spending on healthcare is higher (11% of its wealth) than the other countries spend (9.8% in the UK). The country has more doctors and hospital beds per patient than the UK. As per the data published in “The Burden of Stroke in Europe” report conducted by King’s College London for the Stroke Alliance for Europe, the number of stroke cases is around 88,922, which is 51.7 strokes per 100,000 inhabitants annually in Germany. The prevalence of stroke in Germany was around 526,774, accounting for 338.5 strokes per 100,000 inhabitants. The country also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. The incidence of strokes in Germany is estimated to increase by 30% by 2035. Also, the prevalence and mortality rates are expected to rise to 19% and 40%, respectively, by 2035.

Europe Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Europe Embolotherapy Market Segmentation

The Europe embolotherapy market is segmented into product, disease indication, procedure, end user, and country.
Based on product, the market is segmented into embolic agents and support devices.The embolic agents segment registered the largest market share in 2022.

Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others.The cancer segment held the largest market share in 2022.

Based on procedure, the Europe embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE).The transcatheter arterial embolization (TAE) segment held the largest market share in 2022.

Based on end user, the Europe embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Cancer/Tumor Profiling Market by Technology, Cancer Type, Biomarker Type, Application - Global Forecast to 2027

  • $ 4950
  • November 2022
  • 295 pages

The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly driven ...

  • World
  • United States
  • Cancer
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on